Vienna Institute For Research In Ocular Surgery
Clinical trials sponsored by Vienna Institute For Research In Ocular Surgery, explained in plain language.
-
Can a stronger eylea dose cut eye injections in half?
Disease control OngoingThis study tests whether switching wet AMD patients who don't respond well to the standard 2mg dose of aflibercept (Eylea) to a higher 8mg dose can extend the time between injections while keeping vision stable. Fifty adults who have already had at least four 2mg injections will …
Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a common diabetes drug slow cataracts?
Knowledge-focused OngoingThis pilot study looks at whether metformin, a standard diabetes medicine, gets into the lens capsule of the eye and can slow the growth of lens cells that cause cataracts. Researchers will collect blood and lens tissue from 40 people with type 2 diabetes and age-related cataract…
Phase: NA • Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:29 UTC